A role for PAR4 in colitis was also suggested in a T-cell transfer colitis mouse model, where treating the mice with the serine protease inhibitor UAMC-00050 ameliorated intestinal inflammation and permeability and decreased the mRNA expression of PAR4 [80]. The gene discussed is F2RL3; the disease is colitis.